Bowon Chemical Amends Annual Report to Strengthen Inventory Disclosure; No Change in Financial Figures, Limited Impact on Shareholder Value

Bowon Chemical filed a correction to its 31st annual business report on June 30, 2026. The correction was to supplement insufficient disclosure on inventory status, adding inventory composition ratio, turnover rate, physical count details, and evaluation information.
There is no change in any financial statement figures before and after the correction, so the amendment has no financial impact on existing shareholder value.
The company reported revenue of 52.2 billion won for the period, up 31.4% year-on-year, and its debt-to-equity ratio improved significantly from 1014% to 193%, confirming a strengthened financial structure.
No dividends have been paid for the last three fiscal years, and there are no plans for treasury stock acquisition or cancellation.
[AI Summary]Bowon Chemical's amendment to its business report is an administrative improvement to enhance inventory disclosure transparency. Since no financial figures were altered, the new information effect for investors is limited. While the confirmed operational improvement and financial restructuring are positive, the dilution from capital expansion and the lack of shareholder return policies remain concerns.